Market Research Report Viral Conjunctivitis Pipeline Review

Viral Conjunctivitis Pipeline Review and
Market Scope 2017
Market Research Hub (MRH) has recently announced the addition of a fresh report,
titled “Viral Conjunctivitis - Pipeline Review, H1 2017” to its report offerings. The
Viral Conjunctivitis (Ophthalmology) pipeline guide reviews of key players
involved in therapeutic development for Viral Conjunctivitis and features dormant
and discontinued projects. The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules developed by Companies in
Phase II, Phase I and Preclinical stages are 2, 1 and 5 respectively.
Request Free Sample Report:
http://www.marketresearchhub.com/enquiry.php?type=S&repid=1049076
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide
Viral Conjunctivitis Pipeline Review, H1 2017, provides an overview of the Viral
Conjunctivitis (Ophthalmology) pipeline landscape.
Viral conjunctivitis, or pinkeye, is a common, self-limiting condition that is typically
caused by adenovirus. Viral conjunctivitis is highly contagious, usually for 10-12
days from onset as long as the eyes are red. Symptoms include itchy eyes, tearing,
redness, discharge and light sensitivity (with corneal involvement). Treatment
includes lubricants, vasoconstrictors and antihistamines.
Report Highlights:
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Viral
Conjunctivitis Pipeline Review, H1 2017, provides comprehensive information on